MacroGenics
MGNX
104 hedge funds and large institutions have $77.4M invested in MacroGenics in 2025 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 24 closing their positions.
32% more capital invested
Capital invested by funds: $58.5M → $77.4M (+$18.9M)
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
3.71% less ownership
Funds ownership: 76.6% → 72.89% (-3.7%)
7% less funds holding
Funds holding: 112 → 104 (-8)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
30% less call options, than puts
Call options by funds: $115K | Put options by funds: $165K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$879K |
| 2 |
Renaissance Technologies
New York
|
+$607K |
| 3 |
Squarepoint
New York
|
+$534K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$521K |
| 5 |
VCM
Voleon Capital Management
Berkeley,
California
|
+$498K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.11M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.94M |
| 3 |
Goldman Sachs
New York
|
-$712K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$493K |
| 5 |
BlackRock
New York
|
-$451K |
MGNX Hedge Fund Activity: Q3 2025 in Review
104 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2025, worth a combined $77.4M — up 32% from $58.5M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of MGNX and 17 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 30 added.
The largest buyer was Morgan Stanley, adding an estimated $879K. The largest seller was Wasatch Advisors, cutting an estimated $2.11M.
- 104 institutional investors held MacroGenics (MGNX) as of Q3 2025, down from 112 in Q2 2025.
- Funds reported $77.4M of MacroGenics stock for Q3 2025, up 32% quarter-over-quarter.
- 17 funds opened new MacroGenics positions in Q3 2025 and 24 closed out, a net change of -7 holders.
- The largest MacroGenics buyer in Q3 2025 was Morgan Stanley, an estimated $879K added.
- The largest MacroGenics seller in Q3 2025 was Wasatch Advisors, an estimated $2.11M sold.
Based on aggregated 13F filings for Q3 2025.